OrthoAccel Technologies Receives $4,999,975 New Financing

  • Feed Type
  • Date
    3/11/2016
  • Company Name
    OrthoAccel Technologies
  • Mailing Address
    6575 West Loop South Bellaire, TX 77401 USA
  • Company Description
    The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption.
  • Website
    http://www.orthoaccel.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,999,975
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 11 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy